课题基金 / 基金详情

项目摘要

项目成果

NAGI G AYAD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Understanding neurogenesis is contingent upon elucidating cell cycle exit. An essential feature of all cell cycle transitions is their irreversibility. Once a commitment to enter a particular cell cycle phase is made, return to the previous phase is not possible. This is in part due to ubiquitin mediated proteolysis pathways that target substrates for proteasomal degradation. Ubiquitin mediated proteolysis pathways contain E1, E2, and E3 enzymes that regulate both the timing and fidelity of degradation events. One of the most important E3 enzymes is a multi-subunit complex named the Anaphase Promoting Complex, or APC. The APC controls both the metaphase to anaphase transition and mitotic exit. The APC is also active during cell cycle exit and differentiation of neuronal precursors. The APC degrades the ubiquitin ligase component Skp2, which allows p27kip1 levels to rise, thereby inducing cell cycle exit. The overall goal of this research is to test the hypothesis that ubiquitin mediated proteolysis controlled by the ubiquitin ligase the Anaphase Promoting Complex (APC) is required for cell cycle exit in the developing nervous system. PUBLIC HEALTH RELEVANCE: We are studying the mechanisms controlling neuronal precursor cell proliferation. These mechanisms are often misregulated in neurological diseases and cancers. Our work will identify both targets and small molecule inhibitors of cell cycle transitions, which can be used for both academic clinical researches to treat diseases such as medulloblastoma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting cell-type specific disease phenotypes to promote CNS repair
Epigenetic pathways and cell cycle exit
  • 批准号:
    10630295
  • 项目类别:
  • 资助金额:
    $35.71万
  • 财政年份:
    2020
  • 负责人:
    NAGI G AYAD
  • 依托单位:
Epigenetic pathways and cell cycle exit
  • 批准号:
    10576517
  • 项目类别:
  • 资助金额:
    $35.71万
  • 财政年份:
    2020
  • 负责人:
    NAGI G AYAD
  • 依托单位:
Epigenetic pathways and cell cycle exit
国内基金
海外基金
RIF1蛋白在处理超细后期桥(ultrafine anaphase bridge)和保障基因组稳定的作用
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2019
  • 负责人:
    陈英伟
  • 依托单位: